Why China's rise needs to be taken with a pinch of salt - Pharmaceutical Technology

Though recent dealmaking illustrates China’s rapid rise in global biopharma, experts suggest this could be about to plateau. Though recent dealmaking illustrates China’s rapid rise in global biopharma, experts suggest this could be about to plateau. Daniel Chancellor, Toby Richardson, Malin Jonsson Boezelman, Simon Regnell, Frances Stock Allen, and Daniel Rankin explored why China’s rise could be flattening. Credit: Frankie Fattorini/GlobalData. A closer look at the numbers that paint China as accelerating towards global biopharma dominance and you will find indications that the region’s ascension is not as unassailable as many might think. This was the message a panel of…

Source: Pharmaceutical Technology